...olume Medication W/Adult Mask PT WYE Mouthpiece 7F...ign for fast treatment times , ,Provide fine part...ge of respirable particles) than conventional nebu...ade; disposable nebulizers deliver fast and effect...
...sia and Respiratory Products, ,Westmed designs, m...evices for Anesthesia and Respiratory professional...ts that enhance the clinician's ability to deliver... to the bottom line. , ,Our web site is designed ...
...sia and Respiratory Products, ,Westmed designs, m...evices for Anesthesia and Respiratory professional...ts that enhance the clinician's ability to deliver... to the bottom line. , ,Our web site is designed ...
...akthrough continuous low-flow nebulizer performanc...technology allows for optimal medication and Helio...takes on severe asthma, COPD and pneumonia in both...ith a mask, mouth and T-piece to deliver high-outp...
Medicine Products:(Date:12/2/2008)...- United American Healthcare,Corporation (Nasdaq:...ealthcare,management services to a managed care o...s Board of Directors has approved a share repurcha... up to $1.0 million of its outstanding,common sto...common shares to be purchased in the,open market ...
(Date:12/2/2008)... -- Today, advocates for teen,dating violence edu... at Liz,Claiborne Inc. to launch ,MADE, -- Moms a...Ann and Chris Burke, educators and parents of Lind...boyfriend, are joining efforts with Liz,Claiborne...ion that will,consist of parents, teachers and co...
(Date:12/2/2008)...ll/ -- UnitedHealth Group,(NYSE: UNH ) is givin..."health,care heroes" by learning about childhood ...lementing the programs in their communities. , ...lth literacy initiative,designed to encourage you...aders, to create and implement local hands-on prog...
(Date:12/2/2008)...edure, study says , , TUESDAY, Dec. 2 (H... of epilepsy who don,t respond to drugs would gain...ed quality of life at that, if they had a certain ...a new study that relied on computer modeling to as...region for people with temporal lobe epilepsy. ,...
Breaking Medicine News(10 mins):Health News:United American Healthcare Corporation Announces Stock Repurchase Program 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 3Health News:UnitedHealth Group Grants to Help Students and Educators Combat Childhood Obesity 2Health News:Surgery a Boon for Most Common Form of Epilepsy 2Health News:Surgery a Boon for Most Common Form of Epilepsy 3(Date:12/1/2008)...GO, Dec. 2 A study has ...new technique for imaging the breast, is not affec... status, two factors that limit the effectiveness ...r. Results will be presented today at the annual m...a (RSNA). , , "The ability of PEM to detec...
(Date:12/1/2008)...phatasia Treated With ENB-0040 at Children,s Hospi... MONTREAL, Dec. 1 Enobia Pharma, a...eloping novel therapeutics for serious bone disord... in its clinical program for hypophosphatasia was ...Therapy (ERT) with ENB-0040 for the treatment of t...
(Date:12/1/2008)...duled for Tuesday, December 9 at 11:00 am ET to Di...SOUTH SAN FRANCISCO, Calif., Dec. 1 /PRNewswire-...q: SNSS ), a biopharmaceutical company focused o...ology therapeutics, today announced new data from ... (AML) will be presented during the 50th American ...
(Date:11/28/2008)...November 28 German biotech company...cialized HIV monitoring and,AIDS patient follow-u...s. In,the year 2008, 2.5 million patient tests ha...ighly affordable "CyFlow" system, supporting alrea...S. Due to introduction of the,Partec innovation, ...
Breaking Medicine Technology:New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2TopoTarget Successfully Buys Back Full Control of Belinostat 4752 1TopoTarget Successfully Buys Back Full Control of Belinostat 4752 2TopoTarget Successfully Buys Back Full Control of Belinostat 4752 3TopoTarget Successfully Buys Back Full Control of Belinostat 4752 4TopoTarget Successfully Buys Back Full Control of Belinostat 4752 5TopoTarget Successfully Buys Back Full Control of Belinostat 4752 6TopoTarget Successfully Buys Back Full Control of Belinostat 4752 7Fufeng Announces 2007 Annual Results 4750 1Fufeng Announces 2007 Annual Results 4750 2Fufeng Announces 2007 Annual Results 4750 3Ortho Evra Patch Makers Settling Cases 4749 1Ortho Evra Patch Makers Settling Cases 4749 2Europe spends nearly twice as much as US on nanotech risk research 4747 1Europe spends nearly twice as much as US on nanotech risk research 4747 2... Therapeutics Inc.,(OTCBB:MIVT) (FWB:MIV), a leadi...ings and advanced drug delivery systems for,cardio...ces, today,announced that a recent Company sponsor...tific,s certified bare metal stent platform,which...r-free drug,delivery system met critical "FDA Draf...
...rograms to be Presented, SOUTH SAN FRANCISCO, Cali...inetics, Incorporated announced,today that four po...ed at the 2007 Annual Meeting of the American Asso... April 14- 18, 2007 in,Los Angeles, CA. These post...ytokinetics and will present data evaluating,ispin...
Other Medicine Technology:MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines 2MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines 3MIV Therapeutics Announces Pivotal Test Results Further Validating,Company Stent Coatings Meet Critical FDA Fatigue Guidelines 4Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 2Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 3Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 4Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 5Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 6Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 7